Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

iPSC Culture and Differentiation

Active
75N98027Q00053 Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhasePresolicitation
Posted

Presolicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts2 people available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA
Contacts
Michael L Falzone

Full Description

Show more

NOTICE OF INTENT – SOLE-SOURCE ACQUISITION Notice No.:


The National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS), intends to award a Firm-Fixed-Price Purchase Order to Creative Biolab Inc. for culture all cells and differentiate them, expand their cell populations to more than 20 million, collect them, verify cell count, and send them back to us.




Description of the Requirement



The primary objective of this study is to sequence and analyze the 4q35 locus on Chromosome 4 for several years.  This locus is a gene-poor and extremely long (>100K) region of DNA that consists of many repetitive sequences which makes sequencing and analysis extremely difficult.  To sequence this locus using Nanopore Sequencing technology.  To expand the number of samples for our experiment, we looked for a company that can handle numerous cell lines and follow the protocol that we provide.  Creative Biolabs is the only company/research institute that has been able to perform differentiation within 3 months and has the ability to follow our protocol with numerous cell lines.



Justification for the Proposed Sole-Source Acquisition



The Government intends to solicit from a single source pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.



Only Creative Biolabs was willing to follow our exact protocol and had the logistical capacity to handle the large number of cell lines that we need to analyze, which is vital to research at the National Institute of Environmental Health Sciences.



Response Information



This notice is not a request for competitive quotations or proposals. However, interested parties that believe they can meet the Government's requirements may submit a capability statement demonstrating their ability to provide the required preventive maintenance and remedial repair services for the specified instrument and meet all applicable technical and operational requirements.


The Government will review timely submissions to determine whether another responsible source is capable of satisfying the requirement and whether a competitive acquisition is appropriate.



The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source can satisfy the requirement.



Capability statements must be submitted electronically to contact@example.gov no later than 9:00 a.m. EDT on November 13, 2026.



Please reference Notice No. 75N98027Q00053 in the subject line of the submission.

Similar Contracts

Same NAICS industry code

NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposal issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an unrestricted, IDIQ contract focused on Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC). The scope of work includes the purchase and storage of VAC, the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract features a ceiling price of 800 million dollars and a long-term performance horizon, consisting of five one-year ordering periods for VAC and direct purchases starting December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The contractor is required to produce VAC with a minimum capacity of 1.0 million doses and maintain storage on their premises under strict quality control and temperature monitoring standards. Due to the nature of the material, live FMDV is classified as a Tier 1 Select Agent, requiring specific authorization from the CDC/APHIS and adherence to rigorous shipping and security restrictions. Award will be based on the most advantageous offer, evaluating technical capability, past performance, and price, with technical and past performance factors weighted equally. Proposals must be submitted electronically in four separate volumes by November 10, 2026.
Mrpbs Minneapolis Mn

POSTED

7 days ago

DEADLINE

in 7 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS